The deal is valued at $51.8 million based Aamani Healthcare Group has 2021 annual net income of $2.25 million, on Revenue of $6.08 million, leveraging as assets base of $11.96 million. The transaction multiple was based on industry 23, which in this particular industry was conservative considering the ILIM planned rollup and acquisitions.